Delivery Order SPE2DB22D2206-SPE2DB25FJT96
Award Date 9/4/25
Potential Completion Date 9/25/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,691.34 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 ml vials on August 28, 2025, with an ultimate completion date of September 19, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of ONIVYDE 43 mg/10 ml vials, with a firm fixed price ceiling value of $10,691.34 and an ultimate completion date of October 8, 2025. This non-set-aside, competitively awarded delivery order is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of ONIVYDE 43 mg/10 ml vials valued at $5,345.67 with a firm fixed price structure. This non-set-aside delivery order is scheduled for ultimate completion by July 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,127.56 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 mL vials. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $3,563.78 delivery order from the Defense Logistics Agency (DLA) on April 22, 2025, for ONIVYDE 43 mg/10 mL vials. This firm fixed-price contract, with an ultimate completion date of May 13, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- This federal contract award, valued at $10,112.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,009.28 to AmerisourceBergen Drug Corp on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed-price, non-set-aside delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The delivery order represents a small-value...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $10,976.50 to AmerisourceBergen Drug Corp on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX). The order is to be fulfilled at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,708.00 to AmerisourceBergen Drug Corp on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order, issued under contract number 4569424241, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation....
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $10,218.17 to AmerisourceBergen Drug Corp on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement valued through December 2026. The delivery order...